EP PerMed will fund 22 new research projects with around €34.4 million under its Joint Transnational Call 2025 “Pharmacogenomic Strategies for Personalised Medicine Approaches (PGxPM2025)”.
The 22 projects will involve more than 140 research groups from 24 countries and European regions. They will start their work in 2026 and run for three years. Detailed call statistics are available here. Information on all successful consortia can be found in the EP PerMed project database. Individual projects will be showcased on LinkedIn over the coming weeks, so follow us to stay tuned.
The JTC2025 Project Booklet (PDF) is also available for download.
EP PerMed’s next Joint Transnational Call 2026 (JTC2026) “Personalised Medicine for CARdiovascular, MEtabolic, and kidNey diseases (CARMEN2026)” was announced in November 2025 and is open for submission until 10 February 2026.